日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Impact of being small for gestational age in neonates born below 600 g birth weight

小于胎龄儿（出生体重低于 600 克）的影响

期刊:Pediatric Research
影响因子:3.1
doi:10.1038/s41390-025-04202-x
Jernej, Raphaela; Fuiko, Renate; Binder, Julia; Kiss, Herbert; Klebermass-Schrehof, Katrin; Grill, Agnes; Berger, Angelika; Goeral, Katharina
发表日期：2026
文献求助 收藏

Video-Based Evaluation of Checklist Adherence on a Neonatal Intensive Care Unit: A Prospective Observational Study

基于视频的新生儿重症监护病房检查清单执行情况评估：一项前瞻性观察研究

期刊:Acta Paediatrica
影响因子:2.1
doi:10.1111/apa.70288
Kessler, Lisa; Schwarz, Hannah; Bibl, Katharina; Dvorsky, Robyn; Lietz, Andrea; Strasser, Lena; Roth, Vanessa; Haderer, Moritz; Klebermass-Schrehof, Katrin; Werther, Tobias; Berger, Angelika; Wagner, Michael
发表日期：2026
文献求助 收藏

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2025

欧洲呼吸窘迫综合征管理共识指南：2025

期刊:
影响因子:
doi:10.1159/000551062
Sweet, David G; Carnielli, Virgilio P; Greisen, Gorm; Hallman, Mikko; Klebermass-Schrehof, Katrin; Lavizzari, Anna; Ozek, Eren; Te Pas, Arjan; Roehr, Charles C; Saugstad, Ola D; Simeoni, Umberto; Vento, Maximo; Visser, Gerry H A; Speer, Christian P
发表日期：2026
文献求助 收藏

Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Durvalumab 可延长总生存期，而放射剂量递增 > 66 Gy 可改善不可切除的 III 期非小细胞肺癌的长期局部控制：奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的最新分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17091443
Zehentmayr, Franz; Feurstein, Petra; Ruznic, Elvis; Langer, Brigitte; Grambozov, Brane; Klebermass, Marisa; Hochreiter, Alexandra; Purevdorj, Ayurzana; Gruber, Georg; Minasch, Danijela; Breitfelder, Barbara; Steffal, Claudia; Kirchhammer, Karoline; Stranzl, Heidi; Röder, Falk; Dieckmann, Karin
细胞生物学
STAR
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Durvalumab 与延长无进展生存期相关，同时放化疗可改善老年不可切除 NSCLC III 期患者的局部区域控制和局部控制：奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

期刊:Medical Sciences
影响因子:4.4
doi:10.3390/medsci13040305
Zehentmayr, Franz; Karner, Josef; Stana, Markus; Ruznic, Elvis; Zellinger, Barbara; Klebermass, Marisa; Purevdorj, Ayurzana; Gruber, Georg; Minasch, Danijela; Heilmann, Martin; Moosbrugger, Raphaela; Roeder, Falk; Grambozov, Brane
肺癌
肿瘤
肿瘤免疫
STAR
CLC
发表日期：2025
文献求助 收藏

Cognitive, motor, and behavioral outcomes in preterm infants exposed to opioids

早产儿接触阿片类药物后的认知、运动和行为结果

期刊:Pediatric Research
影响因子:3.1
doi:10.1038/s41390-025-04048-3
Steinbauer, Philipp; Kühnl, Julia; Pichler, Karin; Stummer, Sophie; Klebermass-Schrehof, Katrin; Deindl, Philipp; Lindtner, Claudia; Olischar, Monika; Brandstetter, Sophia; Fuiko, Renate; Berger, Angelika; Giordano, Vito
神经科学
发表日期：2025
文献求助 收藏

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

免疫疗法改善了携带 Kirsten 大鼠肉瘤病毒突变的不可切除非小细胞肺癌 III 期患者的临床结果：奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14030945
Ruznic, Elvis; Klebermass, Marisa; Zellinger, Barbara; Langer, Brigitte; Grambozov, Brane; Purevdorj, Ayurzana; Karner, Josef; Gruber, Georg; Stana, Markus; Minasch, Danijela; Kirchhammer, Karoline; Steffal, Claudia; Stranzl, Heidi; Moosbrugger, Raphaela; Feurstein, Petra; Dieckmann, Karin; Zehentmayr, Franz
肺癌
肿瘤
肿瘤免疫
Rat
微生物学
STAR
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

MLR 和 dMLR 可预测不可切除的 NSCLC III 期患者的局部区域控制和无进展生存期：来自奥地利放射肿瘤肺癌研究协会注册中心 (ALLSTAR) 的结果

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14248876
Hochreiter, Alexandra; Stana, Markus; Klebermass, Marisa; Ruznic, Elvis; Grambozov, Brane; Karner, Josef; Heilmann, Martin; Minasch, Danijela; Purevdorj, Ayurzana; Gruber, Georg; Moosbrugger, Raphaela; Röder, Falk; Zehentmayr, Franz
肺癌
肿瘤
肿瘤免疫
STAR
CLC
发表日期：2025
文献求助 收藏

Brain oxygenation monitoring during neonatal stabilization and resuscitation and its potential for improving preterm infant outcomes: a systematic review and meta-analysis with Bayesian analysis

新生儿稳定和复苏期间脑氧合监测及其改善早产儿预后的潜力：基于贝叶斯分析的系统评价和荟萃分析

期刊:European Journal of Pediatrics
影响因子:2.6
doi:10.1007/s00431-025-06138-0
Bruckner, Marlies; Suppan, Thomas; Suppan, Ena; Schwaberger, Bernhard; Urlesberger, Berndt; Goeral, Katharina; Hammerl, Marlene; Perme, Tina; Dempsey, Eugene M; Springer, Laila; Lista, Gianluca; Szczapa, Tomasz; Fuchs, Hans; Karpinski, Lukasz; Bua, Jenny; Law, Brenda; Buchmayer, Julia; Kiechl-Kohlendorfer, Ursula; Cerar, Lilijana Kornhauser; Schwarz, Christoph E; Gründler, Kerstin; Stucchi, Ilaria; Klebermass-Schrehof, Katrin; Schmölzer, Georg M; Pichler, Gerhard
神经科学
发表日期：2025
文献求助 收藏

Cerebral Oxygenation During Transition and Amplitude-Integrated Electroencephalography Signals: An Ancillary Study to the COSGOD-III Trial

过渡期脑氧合和振幅整合脑电信号：COSGOD-III试验的辅助研究

期刊:Acta Paediatrica
影响因子:2.1
doi:10.1111/apa.70190
Schreiner, Christina; Goeral, Katharina; Hammerl, Marlene; Klebermass-Schrehof, Katrin; Avian, Alexander; Neubauer, Vera; Kiechl-Kohlendorfer, Ursula; Pfurtscheller, Daniel; Griesmaier, Elke; Pichler, Gerhard
信号转导
神经科学
发表日期：2025
文献求助 收藏